These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32535015)

  • 41. Foot-and-mouth disease virus strains isolated in Vietnam during 2010-2019: genetic characterization and antigenic relatedness to the Euro SA vaccine.
    Taffarel AI; Barrios Benito MY; Hung VV; Cardillo S; Phuong NT; Caldevilla C; Galdo Novo S
    Arch Virol; 2024 Feb; 169(3):44. PubMed ID: 38341400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The serological response against foot and mouth disease virus elicited by repeated vaccination of dairy cattle.
    Elnekave E; Dekker A; Eble P; van Hemert-Kluitenberg F; Gelman B; Storm N; Klement E
    Vaccine; 2016 Sep; 34(41):4920-4926. PubMed ID: 27576078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological and molecular epidemiology of foot-and-mouth disease viruses in agro-pastoralist livestock herds in the kachia grazing reserve, Nigeria.
    Ehizibolo DO; De Vleeschauwer AR; Haegeman A; Lefebvre D; Nwosuh CI; Umoh JU; Okolocha EC; Kazeem HM; Van Borm S; De Clercq K
    Transbound Emerg Dis; 2019 Jul; 66(4):1575-1586. PubMed ID: 30901506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized controlled field trial assessing foot and mouth disease vaccine effectiveness in Gondar Zuria district, Northwest Ethiopia.
    Jemberu WT; Molla W; Fentie T
    Prev Vet Med; 2020 Oct; 183():105136. PubMed ID: 32977170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V; Pappalardo JS; Langellotti C; Smitsaart E; Fondevila N; Zamorano P
    Vaccine; 2014 Apr; 32(19):2167-72. PubMed ID: 24631088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of simultaneous foot-and-mouth disease and Escherichia coli vaccination on the immunity of pregnant cows and their calves.
    Tuncer-Göktuna P; Malal ME; Sareyyüpoğlu B; Çokçalişkan C; Taşçene N; Uzun EA; Arslan A; Gündüzalp C; Balci GN; Çökülgen T; Asar E; Ateşoğlu A; Gülyaz V
    Prev Vet Med; 2022 Jul; 204():105645. PubMed ID: 35453090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenges for Serology-Based Characterization of Foot-and-Mouth Disease Outbreaks in Endemic Areas; Identification of Two Separate Lineages of Serotype O FMDV in Uganda in 2011.
    Namatovu A; Belsham GJ; Ayebazibwe C; Dhikusooka MT; Wekesa SN; Siegismund HR; Muwanika VB; Tjørnehøj K
    Transbound Emerg Dis; 2015 Oct; 62(5):522-34. PubMed ID: 24118785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Horsington J; Nfon C; Gonzales JL; Singanallur N; Bittner H; Vosloo W
    Vaccine; 2018 Oct; 36(41):6095-6102. PubMed ID: 30195485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foot-and-mouth disease status in India during the second decade of the twenty-first century (2011-2020).
    Subramaniam S; Mohapatra JK; Sahoo NR; Sahoo AP; Dahiya SS; Rout M; Biswal JK; Ashok KS; Mallick S; Ranjan R; Jana C; Singh RP
    Vet Res Commun; 2022 Dec; 46(4):1011-1022. PubMed ID: 36190601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
    Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
    Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deoptimization of FMDV P1 Region Results in Robust Serotype-Independent Viral Attenuation.
    Medina GN; Spinard E; Azzinaro PA; Rodriguez-Calzada M; Gutkoska J; Kloc A; Rieder EA; Taillon BE; Mueller S; de Los Santos T; Segundo FD
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological analysis of an outbreak of foot-and-mouth disease (serotype SAT2) on a large dairy farm in Kenya using regular vaccination.
    Lyons NA; Stärk KD; van Maanen C; Thomas SL; Chepkwony EC; Sangula AK; Dulu TD; Fine PE
    Acta Trop; 2015 Mar; 143():103-11. PubMed ID: 25447264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.
    Rodriguez LL; Barrera J; Kramer E; Lubroth J; Brown F; Golde WT
    Vaccine; 2003 Sep; 21(25-26):3751-6. PubMed ID: 12922108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the effectiveness of foot-and-mouth disease vaccination of animals in the buffer zone of the Republic of Armenia in 2016-2020.
    Kharatyan S; Sargsyan K; Elbakyan H; Markosyan T; Tumanyan P; Hakobyan V; Sargsyan V; Badalyan M; Chobanyan G; Achenbach JE
    BMC Vet Res; 2023 Sep; 19(1):176. PubMed ID: 37773157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME; El-Deeb AH; Zeidan SM; Hussein HA; Abu-El-Naga HI
    Vet Microbiol; 2017 Oct; 210():1-7. PubMed ID: 29103677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.